$ENZ breakout climber $5.90 called 6/6/14 $4.71
Post# of 44
Posted On: 08/26/2014 8:10:39 PM
$ENZ breakout climber $5.90
called 6/6/14 $4.71
Shares Outstanding: 33.28M
Float: 16.72M
10-Q 5/14/14
Website
100% Buy
Press Releases
Thursday, July 31, 2014
THOMAS C WRIGHT, MD, WORLD RECOGNIZED WOMEN’S HEALTH SCIENCES AUTHORITY, JOINS ENZO BIOCHEM’S CLINICAL DIVISION
Tuesday, July 29, 2014
Enzo Biochem Announces August 18, 2014 as Date of Markman Hearing in Patent Infringement Lawsuit Against Leading Life Sciences Companies
Monday, June 30, 2014
Enzo Biochem Added to Russell 2000 and Russell 3000 Indexes
Monday, June 23, 2014
ENZO BIOCHEM ANNOUNCES SETTLEMENT AGREEMENT WITH PERKINELMER
Monday, June 09, 2014
ENZO BIOCHEM REPORTS STRONG THIRD FISCAL QUARTER RESULTS
Friday, June 06, 2014
ENZO BIOCHEM AWARDED U.S. PATENT ON MORE EFFICIENT VECTOR FOR USE IN GENE THERAPY
Tuesday, June 03, 2014
ENZO BIOCHEM SCHEDULES TELECONFERENCE TO DISCUSS THIRD QUARTER RESULTS TUESDAY, JUNE 10, 2014 AT 8:30 AM E.T.
Friday, May 30, 2014
ENZO BIOCHEM UNIT PARTNERS WITH INNATE PHARMA S.A. TO VALIDATE KEY SYSTEM FOR ANTIBODY DRUG CONJUGATE DEVLOPMENT
Friday, May 30, 2014
ENZO BIOCHEM ANNOUNCES APPOINTMENT OF JAMES M. O’BRIEN AS SENIOR VP, FINANCE
Thursday, May 29, 2014
ENZO BIOCHEM TO PRESENT AT THE JEFFERIES 2014 GLOBAL HEALTHCARE CONFERENCE
Thursday, April 24, 2014
ENZO BIOCHEM ANNOUNCES SETTLEMENT AGREEMENT WITH AFFYMETRIX
Tuesday, March 11, 2014
ENZO BIOCHEM REPORTS ACROSS THE BOARD SECOND QUARTER 2014 IMPROVED RESULTS
Monday, March 10, 2014
ENZO BIOCHEM SCHEDULES TELECONFERENCE TO DISCUSS SECOND QUARTER RESULTS WEDNESDAY, MARCH 12, 2014 AT 8:30 AM E.T.
Tuesday, February 18, 2014
ENZO BIOCHEM’S CLINICAL LAB AND NUCLEA BIOTECHNOLOGIES JOIN TO MARKET NEW TEST FOR CERTAIN HIGH RISK BREAST CANCER PATIENTS
Tuesday, January 07, 2014
ENZO BIOCHEM ANNOUNCES UPCOMING LITIGATION SCHEDULE
Monday, January 06, 2014
FEDERAL COURT AWARDS ENZO BIOCHEM OVER $61 MILLION IN
called 6/6/14 $4.71
Shares Outstanding: 33.28M
Float: 16.72M
10-Q 5/14/14
Website
100% Buy
Press Releases
Thursday, July 31, 2014
THOMAS C WRIGHT, MD, WORLD RECOGNIZED WOMEN’S HEALTH SCIENCES AUTHORITY, JOINS ENZO BIOCHEM’S CLINICAL DIVISION
Tuesday, July 29, 2014
Enzo Biochem Announces August 18, 2014 as Date of Markman Hearing in Patent Infringement Lawsuit Against Leading Life Sciences Companies
Monday, June 30, 2014
Enzo Biochem Added to Russell 2000 and Russell 3000 Indexes
Monday, June 23, 2014
ENZO BIOCHEM ANNOUNCES SETTLEMENT AGREEMENT WITH PERKINELMER
Monday, June 09, 2014
ENZO BIOCHEM REPORTS STRONG THIRD FISCAL QUARTER RESULTS
Friday, June 06, 2014
ENZO BIOCHEM AWARDED U.S. PATENT ON MORE EFFICIENT VECTOR FOR USE IN GENE THERAPY
Tuesday, June 03, 2014
ENZO BIOCHEM SCHEDULES TELECONFERENCE TO DISCUSS THIRD QUARTER RESULTS TUESDAY, JUNE 10, 2014 AT 8:30 AM E.T.
Friday, May 30, 2014
ENZO BIOCHEM UNIT PARTNERS WITH INNATE PHARMA S.A. TO VALIDATE KEY SYSTEM FOR ANTIBODY DRUG CONJUGATE DEVLOPMENT
Friday, May 30, 2014
ENZO BIOCHEM ANNOUNCES APPOINTMENT OF JAMES M. O’BRIEN AS SENIOR VP, FINANCE
Thursday, May 29, 2014
ENZO BIOCHEM TO PRESENT AT THE JEFFERIES 2014 GLOBAL HEALTHCARE CONFERENCE
Thursday, April 24, 2014
ENZO BIOCHEM ANNOUNCES SETTLEMENT AGREEMENT WITH AFFYMETRIX
Tuesday, March 11, 2014
ENZO BIOCHEM REPORTS ACROSS THE BOARD SECOND QUARTER 2014 IMPROVED RESULTS
Monday, March 10, 2014
ENZO BIOCHEM SCHEDULES TELECONFERENCE TO DISCUSS SECOND QUARTER RESULTS WEDNESDAY, MARCH 12, 2014 AT 8:30 AM E.T.
Tuesday, February 18, 2014
ENZO BIOCHEM’S CLINICAL LAB AND NUCLEA BIOTECHNOLOGIES JOIN TO MARKET NEW TEST FOR CERTAIN HIGH RISK BREAST CANCER PATIENTS
Tuesday, January 07, 2014
ENZO BIOCHEM ANNOUNCES UPCOMING LITIGATION SCHEDULE
Monday, January 06, 2014
FEDERAL COURT AWARDS ENZO BIOCHEM OVER $61 MILLION IN
(0)
(0)